Physician

Patrick J Colarusso, D.O.

According to 2025 Medicare claims, Patrick Colarusso, D.O. (NPI: 1144238825) practices medical oncology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is CENTER FOR UROLOGIC CARE OF BERKS CO PC (NPI: 1396742623; TIN: 231727298) and primary practice location at 19610-3222.

Colarusso's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 250 traditional Medicare patients, billed 653 HCPCS/CPT codes, and received $43,455 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,113 prescription claims across 170 beneficiaries totaling $2,247,939 in drug costs, led by Kisqali (Ribociclib Succinate). 2020 DME data shows 73 claims. Open Payments data shows 10 records totaling $579. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $46,809 and ending at $43,455. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $652,755 to $2,247,939. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,104 to $1,979.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	282	702	$46,809
2016	326	890	$60,911
2017	343	919	$70,599
2018	307	703	$51,423
2019	355	867	$65,302
2020	332	711	$53,313
2021	330	637	$52,252
2022	272	613	$46,518
2023	253	555	$42,479
2024	250	653	$43,455

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	130	539	$652,755
2016	175	805	$1,403,720
2017	170	872	$1,635,708
2018	170	728	$1,823,814
2019	208	1,226	$3,036,444
2020	216	1,378	$2,903,261
2021	218	1,326	$2,832,983
2022	245	1,727	$4,146,693
2023	214	1,676	$3,118,596
2024	170	1,113	$2,247,939

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$1,026
2016	N/R	N/R	N/R
2017	N/R	11	$405
2018	N/R	69	$4,891
2019	N/R	26	$4,149
2020	N/R	73	$7,611
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	31	31	$122
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	48	77	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	351	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	25	27	$48
99441	Telephone medical discussion with physician, 5-10 minutes	11	12	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kisqali	Ribociclib Succinate	35	1,024	$499,438
Ibrance	Palbociclib	30	833	$456,369
Erleada	Apalutamide	21	630	$297,838
Abiraterone Acetate	Abiraterone Acetate	265	7,950	$229,403
Calquence	Acalabrutinib Maleate	12	360	$170,106

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$579	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick J. Colarusso, D.O.?

Tedicare shows public-source Medicare data for Patrick J. Colarusso, D.O. (NPI 1144238825), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick J. Colarusso, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Patrick J. Colarusso, D.O.?

Patrick J. Colarusso, D.O. is linked to CENTER FOR UROLOGIC CARE OF BERKS CO PC (billing NPI 1396742623) in the available physician profile data.

Does Patrick J. Colarusso, D.O. have Open Payments data?

Patrick J. Colarusso, D.O. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.